Ostensen, Monika; Förger, Frauke (2011). Treatment with biologics of pregnant patients with rheumatic diseases. Current opinion in rheumatology, 23(3), pp. 293-8. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/BOR.0b013e328344a732
Full text not available from this repository. (Request a copy)Due to limited human pregnancy experience safety issues in regard to children exposed antenatally to biological drugs are still under debate. A survey of new published experience on biological agents during pregnancy is necessary to assist clinicians with adequate counseling and management of patients who desire children.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology |
UniBE Contributor: |
Oestensen, Monika Elisabeth, Förger, Frauke |
ISSN: |
1040-8711 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:26 |
Last Modified: |
05 Dec 2022 14:07 |
Publisher DOI: |
10.1097/BOR.0b013e328344a732 |
PubMed ID: |
21346578 |
Web of Science ID: |
000288939100014 |
URI: |
https://boris.unibe.ch/id/eprint/9314 (FactScience: 215012) |
Actions (login required)
 |
Edit item |